Structure-function properties of prolyl oligopeptidase family enzymes

Cell Biochemistry and Biophysics

Volumn 44, Issue 3, 2006, Pages 349-365

  Rea, Dean ^a   Fülöp, Vilmos ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Acylaminoacyl peptidase; Catalytic triad; Dipeptidyl peptidase IV; Oligopeptidase B; Prolyl oligopeptidase; Serine peptidase

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; PROLYL ENDOPEPTIDASE; SERINE PROTEINASE;

ANIMAL; BINDING SITE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; CONFERENCE PAPER; GENETICS; HUMAN; KINETICS; METABOLISM; PROTEIN TERTIARY STRUCTURE; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIGENS, CD26; BINDING SITES; CATALYSIS; HUMANS; KINETICS; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; SERINE ENDOPEPTIDASES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33646869457     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1385/CBB:44:3:349     Document Type: Conference Paper

References (136)

1. Puente, X. S., Sanchez, L. M., Overall, C. M. and Lopez-Otin, C. (2003) Human and mouse proteases: a comparative genomic approach. Nat. Rev. Genet. 4, 544-558.
2. Rawlings, N. D., Tolle, D. P., and Barrett, A. J. (2004) MEROPS: the peptidase database. Nucleic Acids Res. 32, 160-164.
3. Holmquist, M. (2000) Alpha/beta-hydrolase fold enzymes: structures, functions and mechanisms. Curr. Protein Pept. Sci. 1, 209-235.
4. Dodson, G. and Wlodawer, A. (1998) Catalytic triads and their relatives. Trends Biochem. Sci. 23, 347-352.
5. Venalainen, J. I., Juvonen, R. O., and Mannisto, P. T. (2004) Evolutionary relationships of the prolyl oligopeptidase family enzymes. Eur. J. Biochem. 271, 2705-2715.
6. Walter, R., Shlank, H., Glass, J. D., Schwartz, I. L., and Kerenyi, T. D. (1971) Leucylglycinamide released from oxytocin by human uterine enzyme. Science 173, 827-829.
7. Koida, M. and Walter, R. (1976) Post-proline cleaving enzyme. Purification of this endopeptidase by affinity chromatography. J. Biol. Chem. 251, 7593-7599.
8. Wilk, S. (1983) Prolyl endopeptidase. Life Sci. 33, 2149-2157.
9. Mentlein, R. (1988) Proline residues in the maturation and degradation of peptide-hormones and neuropeptides. FEBS Lett. 234, 251-256.
10. Cunningham, D. F. and O'Connor, B. (1997) Proline specific peptidases. Biochim. Biophys. Acta 1343, 160-186.
11. Maes, M., Goossens, F., Scharpe, S., Meltzer, H. Y., D'Hondt, P., and Cosyns, P. (1994) Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression. Biol. Psychiatry 35, 545-552.
12. Maes, M., Goossens, F., Scharpe, S., Calabrese, J., Desnyder, R., and Meltzer, H. Y. (1995) Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs. Psychiatry Res. 58, 217-225.
13. Yoshimoto, T., Kado, K., Matsubara, F., Koriyama, N., Kaneto, H. and Tsuru D. (1987) Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect. J. Pharmacobiodyn. 10, 730-735.
14. Morain, P., Lestage, P., De Nanteuil, G., et al. (2002) S17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies. CNS Drug Rev. 8, 31-52.
15. Shinoda, M.., Toide, K., Ohsawa, I., and Kohsaka, S. (1997) Specific inhibitor for prolyl endopeptidase suppresses the generation of amiloid βprotein in NG108-15 cells. Biochem. Biophys. Res. Commun. 235, 641-645.
16. Kato, A., Fukunari, A., Sakai, Y., and Nakajima, Z. (1997) Prevention of amyloid-like deposition by a selective prolyl endopeptidase inhibitor, Y-29794, in senescence-accelerated mouse. J. Pharmacol. Exp. Ther. 283, 328-335.
17. Petit, A., Barelli, H., Morain, P., and Checler, F. (2000) Novel proline endopeptidase inhibitors do not modify Aβ40/42 formation and degradation by human cells expressing wild-type and Swedish mutated β-amyloid precursor protein. Br. J. Pharmacol. 130, 1613-1617.
18. Welches, W. R., Brosnihan, K. B., and Ferrario, C. M. (1993) A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase. Life Sci. 52, 1461-1480.
19. Santana, J. M., Grellier, P., Schrevel, J., and Teixeira, A. R. (1997) A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV. Biochem. J. 325, 129-137.
20. Grellier, P., Vendeville, S., Joyeau, R., et al. (2001) Trypanosoma cruzi prolyl oligopeptidase Tc80 is involved in nonphagocytic mammalian cell invasion by trypomastigotes. J. Biol. Chem. 276, 47,078-47,086.
21. Bastos, I. M., Grellier, P., Martins, N. F., et al. (2005) Molecular, functional and structural properties of the prolyl oligopeptidase of Trypanosoma cruzi (POP Tc80) that is required for parasite entry into mammalian cells. Biochem. J. 388, 29-38.
22. Fülöp, V., Böcskei, Z., and Polgár, L. (1998) Prolyl oligopeptidase: an unusual β-propeller domain regulates proteolysis. Cell 94, 161-170.
23. 2. Cell 83, 1047-1058.
24. Lambright, D. G., Sondek, J., Bohm, A., Skiba, N. P., Hamm, H. E., and Sigler, P. B. (1996) The 2.0 A crystal structure of a heterotrimeric G protein. Nature 379, 311-319.
25. Sondek, J., Bohm, A., Lambright, D. G., Hamm, H. E., and Sigler, P. B. (1996) Crystal structure of a G-protein βγ dimer at 2.1 A resolution. Nature 379, 369-374.
26. 1 structure: unusual haem environments in a nitrite reductase and analysis of factors contributing to β-propeller folds. J. Mol. Biol. 269, 440-455.
27. Fülöp, V. and Jones, D. T. (1999) β-Propellers: structural rigidity and functional diversity. Curr. Opin. Struct. Biol. 9, 715-721.
28. Faber, H. R., Groom, C. R., Baker, H. M., Morgan, W. T., Smith, A., and Baker, E. N. (1995) 1.8 Å structure of the C-terminal domain of rabbit serum hemopexin. Structure 3, 551-559.
29. Li, J., Brick, P., O'Hare, M. C., et al. (1995) Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed β-propeller. Structure 3, 341-349.
30. Polgár, L. (1991) pH-dependent mechanism in the catalysis of prolyl endopeptidase from pig muscle. Eur. J. Biochem. 197, 441-447.
31. Polgár, L. (1992) Prolyl endopeptidase catalysis. A physical rather than a chemical step is rate-limiting. Biochem. J. 283, 647-648.
32. Fülöp, V., Szeltner, Z., and Polgár, L. (2000) Catalysis of serine oligopeptidases is controlled by a gating filter mechanism. EMBO Rep. 1, 277-281.
33. Szeltner, Z., Rea, D., Juhász, T., Renner, V., Fülöp, V., and Polgár, L. (2004) Concerted structural changes in the peptidase and the propeller domains of prolyl oligopeptidase are required for substrate binding. J. Mol. Biol. 340, 627-637.
34. Hasebe, T., Hua, J., Someya, A., Morain, P., Checler, F., and Nagaoka, I. (2001) Involvement of cytosolic prolyl endopeptidase in degradation of p40-phox splice variant protein in myeloid cells. J. Leukoc. Biol. 69, 963-968.
35. Shan, L., Mathews, I. I., and Khosla, C. (2005) Structural and mechanistic analysis of two prolyl endopeptidases: role of interdomain dynamics in catalysis and specificity. Proc. Natl. Acad. Sci. U.S.A. 102, 3599-3604.
36. Harris, M. N., Madura, J. D., Ming, L. J., and Harwood, V. J. (2001) Kinetic and mechanistic studies of prolyl oligopeptidase from the hyperthermophile Pyrococcus furiosus. J. Biol. Chem. 276, 19,310-19,317.
37. Fülöp, V., Szeltner, Z., Renner, V., and Polgár, L. (2001) Structures of prolyl oligopeptidase substrate/inhibitor complexes. Use of inhibitor binding for titration of the catalytic histidine residue. J. Biol. Chem. 276, 1262-1266.
38. Szeltner, Z., Rea, D., Renner, V., Juliano, L., Fülöp, V., and Polgár, L. (2003) Electrostatic environment at the active site of prolyl oligopeptidase is highly influential during substrate binding. J. Biol. Chem. 278, 48,786-48,793.
39. Rosenblum, J. S. and Kozarich, J. W. (2003) Prolyl peptidases: a serine protease subfamily with high potential for drug discovery. Curr. Opin. Chem. Biol. 7, 496-504.
40. Polgár, L., Kollát, E., and Hollósi, M. (1993) Prolyl oligopeptidase catalysis. Reactions with thiono substrates reveal substrate-induced conformational change to be the rate-limiting step. FEBS Lett. 322, 227-230.
41. Szeltner, Z., Rea, D., Renner, V., Fülöp, V., and Polgár, L. (2002) Electrostatic effects and binding determinants in the catalysis of prolyl oligopeptidase. Site-specific mutagenesis at the oxyanion binding site. J. Biol. Chem. 277, 42,613-42,622.
42. Cygler, M., Schrag, J. D., Sussman, J. L., et al. (1993) Relationship between sequence conservation and three-dimensional structure in a large family of esterases, lipases, and related proteins. Protein Sci. 2, 366-382.
43. Halkides, C. J., Wu, Y. Q., and Murray, C. J. (1996) A low-barrier hydrogen bond in subtilisin: 1H and 15N NMR studies with peptidyl trifluoromethyl ketones. Biochemistry 35, 15,941-15,948.
44. Craik, C. S., Roczniak, S., Largman, C., and Rutter, W. J. (1987) The catalytic role of the active site aspartic acid in serine proteases. Science 237, 909-913.
45. Sprang, S., Standing, T., Fletterick, R. J., et al. (1987) The three-dimensional structure of Asn102 mutant of trypsin: role of Asp102 in serine protease catalysis. Science 237, 905-909.
46. Szeltner, Z., Rea, D., Juhasz, T., et al. (2002) Substrate-dependent competency of the catalytic triad of prolyl oligopeptidase. J. Biol. Chem. 277, 44,597-44,605.
47. Fersht, A. R. (1987) Structure and Mechanism in Protein Sciences: A Guide to Enzyme Catalysis and Protein Folding, WH Freeman & Company, New York.
48. Liang, T. C. and Abeles, R. H. (1987) Complex of α-chymotrypsin and N-acetyl-L-leucyl-L-phenylalanyl trifluoromethyl ketone: structural studies with NMR spectroscopy. Biochemistry 26, 7603-7608.
49. Matthews, D. A., Alden, R. A., Birktoft, J. J., Freer, S. T., and Kraut, J. (1975) X-ray crystallographic study of boronic acid adducts with subtilisin BPN' (Novo). A model for the catalytic transition state. J. Biol. Chem. 250, 7120-7126.
50. Bryan, P., Pantoliano, M. W., Quill, S. G., Hsiao, H. Y., and Poulos, T. (1986) Site-directed mutagenesis and the role of the oxyanion hole in subtilisin. Proc. Natl. Acad. Sci. U.S.A. 83, 3743-3745.
51. Braxton, S. and Wells, J. A. (1991) The importance of a distal hydrogen bonding group in stabilizing the transition state in subtilisin BPN'. J. Biol. Chem. 266, 11,797-11,800.
52. Engel, M., Hoffmann, T., Wagner, L., et al. (2003) The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism. Proc. Natl. Acad. Sci. U.S.A. 100, 5063-5068.
53. Hiramatsu, H., Kyono, K., Higashiyama, Y., et al. (2003) The structure and function of human dipeptidyl peptidase IV, possessing a unique eight-bladed β-propeller fold. Biochem. Biophys. Res. Commun. 302, 849-854.
54. Oefner, C., D'Arcy A., Mac Sweeney, A., Pierau, S., Gardiner, R., and Dale, G. E. (2003) High-resolution structure of human apo dipeptidyl peptidase IV/CD26 and its complex with 1-[([2-[(5-iodopyridin-2-yl) amino]-ethyl]amino)- acetyl]-2-cyano-(S)-pyrrolidine. Acta Crystallogr. D 59, 1206-1212.
55. Rasmussen, H. B., Branner, S., Wiberg, F. C., and Wagtmann, N. (2003) Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog. Nat. Struct. Biol. 10, 19-25.
56. Thoma, R., Loffler, B., Stihle, M., Huber, W., Ruf, A., and Hennig, M. (2003) Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV. Structure 11, 947-959.
57. Larsen, N. A., Turner, J. M., Stevens, J. et al. (2002) Crystal structure of a bacterial cocaine esterase. Nat. Struct. Biol. 9, 17-21.
58. Szeltner, Z., Renner, V., and Polgár, L. (2000) Substrate-and pH-dependent contribution of oxyanion binding site to the catalysis of prolyl oligopeptidase, a paradigm of the serine oligopeptidase family. Protein Sci. 9, 353-360.
59. Polgár, L. (1997) A potential processing enzyme in prokaryotes: oligopeptidase B, a new type of serine peptidase. Proteins 28, 375-379.
60. Caler, E. V., Vaena de Avalos, S., Haynes, P. A., Andrews, N. W., and Burleigh, B. A. (1998) Oligopeptidase B-dependent signalling mediates host cell invasion by Trypanosoma cruzi. EMBO J. 17, 4975-4986.
61. 2+ and cyclic AMP elevation in host cell invasion by Trypanosoma cruzi. Infect. Immun. 68, 6602-6610.
62. Morty, R. E., Lonsdale-Eccles, J. D., Morehead, J., et al. (1999) Oligopeptidase B from Trypanosoma brucei, a new member of an emerging subgroup of serine oligopeptidases. J. Biol. Chem. 274, 26,149-26,156.
63. Morty, R. E., Lonsdale-Eccles, J. D., Mentele, R., Auerswald, E. A., and Coetzer, T. H. (2001) Trypanosome-derived oligopeptidase B is released into the plasma of infected rodents, where it persists and retains full catalytic activity. Infect. Immun. 69, 2757-2761.
64. Morty, R. E., Authie, E., Troeberg, L., Lonsdale-Eccles, J. D., and Coetzer, T. H. (1999) Purification and characterisation of a trypsin-like serine oligopeptidase from Trypanosoma congolense. Mol. Biochem. Parasitol. 102, 145-155.
65. Morty, R. E., Pelle, R., Vadasz, I., Uzcanga, G. L., Seeger, W., and Bubis, J. (2005) Oligopeptidase B from Trypanosoma evansi: a parasite peptidase that inactivates atrial natriuretic factor in the bloodstream of infected hosts. J. Biol. Chem. 280, 10,925-10,937.
66. Morty, R. E., Troeberg, L., Pike, R. N., et al. (1998) A trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine, diminazene and suramin. FEBS Lett. 433, 251-256.
67. Morty, R. E., Troeberg, L., Powers, J. C., Ono, S., Lonsdale-Eccles, J. D., and Coetzer, T. H. (2000) Characterisation of the antitrypanosomal activity of peptidyl alpha-aminoalkyl phosphonate diphenyl esters. Biochem. Pharmacol. 60, 1497-1504.
68. Tsuji, A., Yuasa, K., and Matsuda, Y. (2004) Identification of oligopeptidase B in higher plants. Purification and characterization of oligopeptidase B from quiescent wheat embryo, Triticum aestivum. J. Biochem. 136, 673-681.
69. Tsuru, D. and Yoshimoto, T. (1994) Oligopeptidase B: protease II from Escherichia coli. Methods Enzymol. 244, 201-215.
70. Barrett, A. J., Rawlings, N. D., and Woessner, J. F. (2004) Handbook of Proteolytic Enzymes, Academic Press, London.
71. 2+ signalling in mammalian cells. J. Cell. Biol. 136, 609-620.
72. Gérczei, T., Keserü, G. M., and Náray-Szabó, G. (2000) Construction of a 3D model of oligopeptidase B, a potential processing enzyme in prokaryotes. J. Mol. Graph. Model. 18, 7-17.
73. Morty, R. E., Fülöp, V., and Andrews N. W. (2002) Substrate recognition properties of oligopeptidase B from Salmonella enterica serovar Typhimurium. J. Bacteriol. 184, 3329-3337.
74. Polgár, L. (1999) Oligopeptidase B: a new type of serine peptidase with a unique substrate-dependent temperature sensitivity. Biochemistry 38, 15,548-15,555.
75. Hemerly J. P., Oliveira, V., Del Nery E., et al. (2003) Subsite specificity (S3, S2, S1′, S2′ and S3′) of oligopeptidase B from Trypanosoma cruzi and Trypanosoma brucei using fluorescent quenched peptides: comparative study and identification of specific carboxypeptidase activity. Biochem. J. 373, 933-939.
76. Yoshimoto, T., Tabira, J., Kabashima, T., Inoue, S., and Ito, K. (1995) Protease II from Moraxella lacunata: cloning, sequencing, and expression of the enzyme gene, and crystallization of the expressed enzyme. J. Biochem. 117, 654-660.
77. Elovson, J. (1980) Biogenesis of plasma membrane glycoproteins. Purification and properties of two rat liver plasma membrane glycoproteins. J. Biol. Chem. 255, 5807-5815.
78. Durinx, C., Lambeir, A. M., Bosmans, E., et al. (2000) Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. Eur. J. Biochem. 267, 5608-5613.
79. Aertgeerts, K., Ye, S., Shi, L., et al. (2004) N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding. Protein Sci. 13, 145-154.
80. Tiruppathi, C., Ganapathy V., and Leibach, F. H. (1990) Evidence for tripeptide-proton symport in renal brush border membrane vesicles. Studies in a novel rat strain with a genetic absence of dipeptidyl peptidase IV. J. Biol. Chem. 265, 2048-2053.
81. Suzuki, Y., Erickson, R. H., Sedlmayer, A., Chang, S. K., Ikehara, Y., and Kim, Y. S. (1993) Dietary regulation of rat intestinal angiotensin- converting enzyme and dipeptidyl peptidase IV. Am. J. Physiol. 264, 1153-1159.
82. Drucker, D. J. (2001) Minireview: the glucagon-like peptides. Endocrinology 142, 521-527.
83. Ansorge, S., Buhling, F., Kahne, T., et al. (1997) CD26/dipeptidyl peptidase IV in lymphocyte growth regulation. Adv. Exp. Med. Biol. 421, 127-140.
84. Kahne, T., Lendeckel, U., Wrenger, S., Neubert, K., Ansorge, S., and Reinhold, D. (1999) Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review). Int. J. Mol. Med. 4, 3-15.
85. Ludwig, A., Schiemann, F., Mentlein, R., Lindner, B., and Brandt, E. (2002) Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine. J. Leukoc. Biol. 72, 183-191.
86. Ludwig, K., Fan, H., Dobers, J., Berger, M., Reutter, W., and Bottcher, C. (2004) 3D structure of the CD26-ADA complex obtained by cryo-EM and single particle analysis. Biochem. Biophys. Res. Commun. 313, 223-229.
87. Cheng, H. C., Abdel-Ghany M., and Pauli, B. U. (2003) A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis. J. Biol. Chem. 278, 24,600-24,607.
88. Loster, K., Zeilinger, K., Schuppan, D., and Reutter, W. (1995) The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site. Biochem. Biophys. Res. Commun. 217, 341-348.
89. Blanco, J., Valenzuela, A., Herrera, C., Lluis, C., Hovanessian, A. G., and Franco, R. (2000) The HIV-1 gp120 inhibits the binding of adenosine deaminase to CD26 by a mechanism modulated by CD4 and CXCR4 expression. FEBS Lett. 477, 123-128.
90. Herrera, C., Morimoto, C., Blanco, J., et al. (2001) Comodulation of CXCR4 and CD26 in human lymphocytes. J. Biol. Chem. 276, 19,532-19,539.
91. Ishii, T., Ohnuma, K., Murakami, A., et al. (2001) CD26-mediated signalling for T cell activation occurs in lipid rafts through its association with CD45RO. Proc. Natl. Acad. Sci. U.S.A. 98, 12,138-12,143.
92. Busek, P., Malik, R., and Sedo, A. (2004) Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer. Int. J. Biochem. Cell Biol. 36, 408-421.
93. Kumagai, Y., Konishi, K., Gomi, T., Yagishita, H., Yajima, A., and Yoshikawa, M. (2000) Enzymatic properties of dipeptidyl aminopeptidase IV produced by the periodontal pathogen Porphyromonas gingivalis and its participation in virulence. Infect. Immun. 68, 716-724.
94. Takahashi, N. and Sato, T. (2001) Preferential utilization of dipeptides by Porphyromonas gingivalis. J. Dent. Res. 80, 1425-1429.
95. Takahashi, N. and Sato, T. (2002) Dipeptide utilization by the periodontal pathogens Porphyromonas gingivalis, Prevotella intermedia, Prevotella nigrescens and Fusobacterium nucleatum. Oral Microbiol. Immunol. 17, 50-54.
96. Yagishita, H., Kumagai, Y., Konishi, K., Takahashi, Y., Aoba, T., and Yoshikawa, M. (2001) Histopathological studies on virulence of dipeptidyl aminopeptidase IV (DPPIV) of Porphyromonas gingivalis in a mouse abscess model: use of a DPPIV-deficient mutant. Infect. Immun. 69, 7159-7161.
97. Banbula, A., Bugno, M., Goldstein, J., et al. (2000) Emerging family of proline-specific peptidases of Porphyromonas gingivalis: purification and characterization of serine dipeptidyl peptidase, a structural and functional homologue of mammalian prolyl dipeptidyl peptidase IV. Infect. Immun. 68, 1176-1182.
98. Lambeir, A. M., Rea, D., Fülöp, V., et al. (2003) Exploration of the active site of dipeptidyl peptidase IV from Porphyromonas gingivalis. Comparison with the human enzyme. Adv. Exp. Med. Biol. 524, 29-35.
99. Rea, D., Lambeir, A. M., Kumagai, Y., De Meester, I., Scharpé, S., and Fülöp, V. (2004) Expression, purification and preliminary crystallographic analysis of dipeptidyl peptidase IV from Porphyromonas gingivalis. Acta Crystallogr. D 60, 1871-1873.
100. Aertgeerts, K., Ye, S., Tennant, M. G., et al. (2004) Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation. Protein Sci. 13, 412-421.
101. Brandstetter, H., Kim, J. S., Groll, M., and Huber, R. (2001) Crystal structure of the tricorn protease reveals a protein disassembly line. Nature 414, 466-470.
102. Kim, J. S., Groll, M., Musiol, H. J., et al. (2002) Navigation inside a protease: substrate selection and product exit in the tricorn protease from Thermoplasma acidophilum. J. Mol. Biol. 324, 1041-1050.
103. Abbott, C. A., McCaughan, G. W., and Gorrell, M. D. (1999) Two highly conserved glutamic acid residues in the predicted β-propeller domain of dipeptidyl peptidase IV are required for its enzyme activity. FEBS Lett. 458, 278-284.
104. Bjelke, J. R., Christensen, J., Branner, S., et al. (2004) Tyrosine 547 constitutes an essential part of the catalytic mechanism of dipeptidyl peptidase IV. J. Biol. Chem. 279, 34,691-34,697.
105. Hanski, C., Huhle, T., Gossrau, R., and Reutter, W. (1998) Direct evidence for the binding of rat liver DPP IV to collagen in vitro. Exp. Cell. Res. 178, 64-72.
106. Gorrell, M. D., Gysbers, V., and McCaughan, G. W. (2001) CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand. J. Immunol. 54, 249-264.
107. Von Bonin, A., Huhn, J., and Fleischer, B. (1998) Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway. Immunol. Rev. 161, 43-53.
108. Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S. F., and Morimoto, C. (1993) Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261, 466-469.
109. Schrader, W. P., West, C. A., Miczek, A. D., and Norton, E. K. (1990) Characterization of the adenosine deaminase-adenosine deaminase complexing protein binding reaction. J. Biol. Chem. 265, 19,312-19,318.
110. Weihofen, W. A, Liu, J., Reutter, W., Saenger, W., and Fan, H. (2004) Crystal structure of CD26/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface. J. Biol. Chem. 279, 43,330-43,335.
111. De Meester, I., Vanham, G., Kestens, L., et al. (1994) Binding of adenosine deaminase to the lymphocyte surface via CD26. Eur. J. Immunol. 24, 566-570.
112. Gines, S., Marin, M., Mallol, J., et al. (2002) Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction. Biochem. J. 361, 203-209.
113. Strop, P., Bankovich, A. J, Hansen, K. C., Garcia, K. C., and Brünger, A. T. (2004) Structure of a human A-type potassium channel interacting protein DPPX, a member of the dipeptidyl aminopeptidase family. J. Mol. Biol. 343, 1055-1065.
114. + channels. Neuron 37, 449-461.
115. Jerng, H. H., Qian, Y., and Pfaffinger, P. J. (2004) Modulation of Kv4.2 channel expression and gating by dipeptidyl peptidase 10 (DPP10). Biophys. J. 87, 2380-2396.
116. Jones, W. M., Scaloni, A., and Manning, J. M. (1994) Acylaminoacyl- peptidase. Methods Enzymol. 244, 227-231.
117. Jones, W. M., Manning, L. R., and Manning, J. M. (1986) Enzymic cleavage of the blocked amino terminal residues of peptides. Biochem. Biophys. Res. Commun. 139, 244-250.
118. Jones, W. M., Scaloni, A., Bossa, F., Popowicz, A. M., Schneewind, O., and Manning, J. M. (1991) Genetic relationship between acylpeptide hydrolase and acylase, two hydrolytic enzymes with similar binding but different catalytic specificities. Proc. Natl. Acad. Sci. U.S.A. 88, 2194-2198.
119. Farries, T. C., Harris, A., Auffret, A. D., and Aitken, A. (1991) Removal of N-acetyl groups from blocked peptides with acylpeptide hydrolase. Stabilization of the enzyme and its application to protein sequencing. Eur. J. Biochem. 196, 679-685.
120. Naylor, S. L., Marshall, A., Hensel, C., Martinez, P. F., Holley B., and Sakaguchi A. Y. (1989) The DNF15S2 locus at 3p21 is transcribed in normal lung small cell lung cancer. Genomics 4, 355-361.
121. Erlandsson, R., Boldog, F., Persson, B., et al. (1991) The gene from the short arm of chromosome 3, at D3F15S2, frequently deleted in renal cell carcinoma, encodes acylpeptide hydrolase. Oncogene 6, 1293-1295.
122. Scaloni A., Jones, W. M., Pospischil, M., et al. (1992) Deficiency of acylpeptide hydrolase in small-cell lung carcinoma cell lines. J. Lab. Clin. Med. 120, 546-552.
123. Duysen, E. G., Li, B., Xie, W., et al. (2001) Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality. J. Pharmacol. Exp. Ther. 299, 528-535.
124. Richards, P. G., Johnson, M. K., and Ray, D. E. (2000) Identification of acylpeptide hydrolase as a sensitive site for reaction with organophosphorus compounds and a potential target for cognitive enhancing drugs. Mol. Pharmacol. 58, 577-583.
125. Mitta, M., Miyagi, M., Kato, I., and Tsunasawa, S. (1998) Identification of the catalytic triad residues of porcine liver acylamino acid-releasing enzyme. J. Biochem. 123, 924-931.
126. Raphel, V., Giardina, T., Guevel, L., et al. (1999) Cloning, sequencing and further characterization of acylpeptide hydrolase from porcine intestinal mucosa. Biochim. Biophys. Acta 1432, 371-381.
127. Kiss, A. L., Szeltner, Z., Fülöp, V., and Polgár, L. (2004). His507 of acylaminoacyl peptidase stabilizes the active site conformation, not the catalytic intermediate. FEBS Lett. 571, 17-20.
128. Feese, M., Scaloni, A., Jones, W. M., Manning, J. M., and Remington, S. J. (1993) Crystallization and preliminary X-ray studies of human erythrocyte acylpeptide hydrolase. J. Mol. Biol. 233, 546-549.
129. Durand, A., Villard, C., Giardina, T., Perrier, J., Juge, N., and Puigserver, A. (2003) Structural properties of porcine intestine acylpeptide hydrolase. J. Protein Chem. 22, 183-191.
130. Wang, G., Gao, R., Ding, Y., et al. (2002) Crystallization and preliminary crystallographic analysis of acylamino-acid releasing enzyme from the hyperthermophilic archaeon Aeropyrum pernix. Acta Crystallogr. D 58, 1054-1055.
131. Bartlam, M., Wang, G., Yang, H., et al. (2004) Crystal structure of an acylpeptide hydrolase/esterase from Aeropyrum pernix K1. Structure 12, 1481-1488.
132. Laing, W. A. and Christeller, J. T. (1997) A plant chloroplast glutamyl proteinase. Plant Physiol. 114, 715-722.
133. Yamauchi, Y., Ejiri, Y., Sugimoto, T., Sueyoshi, K., Oji, Y., and Tanaka, K. (2001) A high molecular weight glutamyl endopeptidase and its endogenous inhibitors from cucumber leaves. J. Biochem. 130, 257-261.
134. Esnouf, R. M. (1997) An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J. Mol. Graph. 15, 133-138.
135. Kraulis, P. J. (1991) MolScript: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950.
136. Merritt, E. A. and Murphy, M. E. P. (1994) Raster3D version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr. D 50, 869-873.